Four studies reported interleukin-6 levels, showing that the combination of THCQ and CT had some advantage in reducing IL-6 levels in sepsis patients, with a statistically significant difference (MD = −33.55 pg/mL, 95% CI: −52.77 to −14.33; four trials, 301 participants, I2 = 93%). The gene discussed is IL6; the disease is Sepsis.